AGC protein kinase containing FYVE domain and its encoding gene and application
By using CRISPR/Cas9 technology to knock out the AGC protein kinase PsZFPK2 of the FYVE domain in Phytophthora soybean, blocking its hyphae growth, solving the problem of controlling the pathogenicity of Phytophthora soybean and achieving effective inhibition of the disease.
Patent Information
- Application Number
- CN202310026370.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2022-01-10
- Filing Date
- 2023-01-09
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2043-01-09
AI Technical Summary
The mycelial growth of Phytophthora soybean bacteria is a key process for infecting host plants, and the prior art is difficult to effectively control its pathogenicity and disease transmission.
By discovering and using the AGC protein kinase PsZFPK2, which contains the FYVE domain in Phytophthora soybean, the expression or activity of CRISPR/Cas9 knockout technology is used to inhibit its expression or activity, block mycelium growth, thereby reducing pathogenicity and infectious ability.
Effectively slowing down the growth of Phytophthora soybean mycelium and controlling the spread and epidemic of diseases, providing a technical basis for preventing and treating soybean blight.
Smart Images

Figure BDA0004045168930000064 
Figure BDA0004045168930000071 
Figure BDA0004045168930000081
Abstract
Description
Technical Field
[0001] The present invention relates to a novel AGC protein kinase of pathogenic oomycetes and a coding gene and application thereof, in particular to an AGC protein kinase PsZFPK2 containing FYVE from Phytophthora sojae and a coding gene and application thereof. Background Art
[0002] Phytophthora sojae is the pathogen that causes soybean blight. In the 1950s, soybean blight was first discovered and reported in North America. Unlike most phytophthora fungi, it has strong host transformation ability and can infect 26 species of soybean and lupine in the field, but it can only cause damage to soybean. Phytophthora sojae can cause soybean seed rot, plant stem rot, root rot and seedling damping-off, and the disease is often devastating in the seedling stage, resulting in direct economic losses of up to billions of dollars worldwide each year.
[0003] The life cycle of soybean phytophthora is divided into an asexual stage and a sexual stage. In the sexual reproduction stage, soybean phytophthora can form oospores through isothripsis. Oospores have thick walls and rich contents, can withstand extreme environments, survive in the soil for several years, and under suitable conditions, can directly germinate to produce hyphae to infect host plants. In the asexual reproduction stage, the sporangium of soybean phytophthora can directly germinate to form hyphae, or can differentiate to form zoospores, indirectly carrying out the infection cycle of the disease. However, zoospores have a short lifespan, forming resting spores on the surface of the roots, and then directly invading the roots through germinating hyphae or through wounds or natural orifices. Once entering the plant, it parasitizes the plant body in the form of hyphae and continues to expand. After about 15 hours, it turns into necrotic trophic parasitism, and necrotic spots begin to appear on the surface of the host plant.
[0004] In summary, hyphae growth is a necessary process for soybean phytophthora to infect the host. If the hyphae growth can be blocked, the soybean phytophthora infection can be controlled and the large-scale epidemic of the disease can be controlled. Summary of the invention
[0005] Through the research of the inventors, it was found that the AGC protein kinase containing FYVE in soybean Phytophthora pathogenicum is related to the hyphal growth rate and pathogenicity of soybean Phytophthora pathogenicum. Therefore, by controlling the AGC protein kinase containing the FYVE domain, the hyphal growth can be restricted and the pathogenicity can be reduced, thereby controlling (inhibiting or blocking) the large-scale spread and epidemic of soybean Phytophthora disease.
[0006] Therefore, the present invention provides an AGC protein kinase containing FYVE in soybean Phytophthora pathogenic bacteria, named PsZFPK2, whose amino acid sequence is the amino acid sequence shown in SEQ ID No.4 or an amino acid sequence that has a similarity of more than 93%, preferably more than 95%, more preferably more than 98% to the amino acid sequence shown in SEQ ID No.4 and has the same function as the amino acid sequence shown in SEQ ID No.4.
[0007] Generally speaking, the same species includes homologous amino acid sequences (or protein sequences) or nucleic acid sequences with the same or similar functions, especially essential amino acid sequences (essential protein sequences) or essential nucleic acid sequences. Their sequences are not necessarily 100% identical because different strains of the same species are susceptible to various mutations including nonsense mutations due to the influence of geographical conditions, external environment such as temperature, humidity and cultivars, but because of the importance of their functions to the survival or growth of the species, the above mutations will not or will not substantially affect their functions. Therefore, even in the same species, it is allowed to have differences within a certain range from the amino acid sequence of the AGC protein kinase of the present invention as shown in SEQ ID No. 4.
[0008] The amino acid sequence of the present invention may be an amino acid sequence as shown in SEQ ID No. 4, in which one or more amino acid residues are replaced and / or deleted and / or added and which has the same function as the amino acid sequence as shown in SEQ ID No. 4.
[0009] In order to facilitate purification, a fusion protein obtained by connecting a tag to the N-terminus and / or C-terminus of the protein shown in SEQ ID No. 4 can also be obtained; the tag can be Poly-Arg (RRRRR), Poly-His (HHHHHH), FLAG (DYKDDDDK), Strep-tag II (WSHPQFEK), c-myc (EQKLISEEDL) and the like.
[0010] The AGC protein kinase of the present invention is generally derived from soybean phytophthora in nature, that is, generally speaking, it is a natural product, and can also be artificially expressed or synthesized.
[0011] In the present invention, the amino acid sequence of the AGC protein kinase can be specifically shown as SEQ ID No. 4. The protein shown in SEQ ID No. 4 consists of 907 amino acid residues, wherein the sequence of the FYVE domain is the amino acid residue sequence from 360 to 422 at the amino terminal of SEQ ID No. 4.
[0012] The second aspect of the present invention provides the coding gene PsZFPK2 of the above-mentioned AGC protein kinase. The coding gene preferably has a DNA sequence as shown in SEQ ID No.3 or a DNA sequence, such as cDNA or recombinant DNA, having a similarity of more than 75%, more preferably more than 85%, and more preferably more than 95% with the DNA sequence as shown in SEQ ID No.3 and having the same function as the DNA sequence as shown in SEQ ID No.3. For example, in the present invention, the DNA sequence of the AGC protein kinase includes the DNA sequence of the AGC protein kinase present in different strains of Phytophthora sojae (for example, the P6497 strain of Phytophthora sojae).
[0013] In the present invention, the DNA sequence (coding gene and cDNA) of AGC protein kinase can be specifically shown as SEQ ID No.3.
[0014] The third aspect of the present invention provides an RNA sequence obtained by transcribing any one of the above DNA sequences. Such as mRNA, etc. Preferably, the RNA sequence is an RNA sequence having a similarity of more than 75% with the RNA sequence transcribed from the DNA sequence as shown in SEQ ID No.3, more preferably more than 85%, more preferably more than 95% and having the same function as the RNA sequence transcribed from the DNA sequence as shown in SEQ ID No.3. The most preferred RNA sequence is an RNA sequence transcribed from the DNA sequence as shown in SEQ ID No.3.
[0015] The fourth aspect of the present invention provides a biological material related to the above-mentioned AGC protein kinase, encoding gene or the above-mentioned RNA molecule, which is any one of the following D1) to D10):
[0016] D1) an expression cassette containing the encoding gene;
[0017] D2) a recombinant vector containing the coding gene, or a recombinant vector containing the expression cassette described in D1);
[0018] D3) a recombinant microorganism containing the encoding gene, or a recombinant microorganism containing the expression cassette described in D1), or a recombinant microorganism containing the recombinant vector described in D2);
[0019] D4) a transgenic plant cell line containing the encoding gene, or a transgenic plant cell line containing the expression cassette described in D1);
[0020] D5) transgenic plant tissue containing the encoding gene, or transgenic plant tissue containing the expression cassette described in D2);
[0021] D6) a transgenic plant organ containing the encoding gene, or a transgenic plant organ containing the expression cassette described in D2);
[0022] D7) a nucleic acid molecule for inhibiting the expression of the coding gene; preferably, the nucleic acid molecule is a nucleic acid molecule for knocking out the coding gene, or a nucleic acid molecule for silencing the coding gene; wherein the nucleic acid molecule for knocking out the coding gene comprises an RNA molecule with a sequence such as CCAGGCUUAGCGGAACCACUGAA and CCGGCAUGUCAGACACAGCCGCA, or a DNA molecule encoding the RNA molecule as shown in SEQ ID No.37 and SEQ ID No.38 in the sequence table;
[0023] D8) an expression cassette, a recombinant vector, a recombinant microorganism or a transgenic plant cell line containing or expressing the nucleic acid molecule described in D7);
[0024] D9) a nucleic acid molecule that inhibits translation of the RNA molecule;
[0025] D10) An expression cassette, a recombinant vector, a recombinant microorganism or a transgenic plant cell line containing or expressing the nucleic acid molecule described in D9).
[0026] The fifth object of the present invention is to provide the use of the AGC protein kinase, its encoding gene or the RNA molecule or the biological material in controlling (inhibiting or blocking) the growth of oomycete hyphae;
[0027] Preferably, the oomycete is Phytophthora sojae, most preferably Phytophthora sojae P6497.
[0028] The sixth object of the present invention is to provide a method for reducing the pathogenicity of oomycetes and / or reducing the ability of oomycetes to infect hosts, the method comprising obtaining an oomycete with reduced pathogenicity and / or reduced ability to infect hosts by gene knockout, or inhibiting the translation of an RNA sequence, or inhibiting and / or the activity of an AGC protein kinase; the amino acid sequence of the AGC protein kinase containing a FYVE domain is the amino acid sequence shown in SEQ ID No.4; the DNA sequence is a DNA sequence capable of encoding the AGC protein kinase; the RNA is an RNA sequence obtained by transcribing the DNA sequence; and the oomycete is Phytophthora sojae.
[0029] Preferably, the cDNA sequence of the AGC protein kinase is the DNA sequence shown as SEQ ID No.3.
[0030] The present invention also provides a method for controlling (inhibiting or blocking) the growth of oomycete hyphae, which comprises controlling (inhibiting or blocking) the growth of oomycete hyphae by inhibiting the expression of the coding gene of the above-mentioned AGC protein kinase or knocking out the coding gene, or inhibiting the translation of the above-mentioned RNA, or inhibiting and / or inactivating the activity of the AGC protein kinase as described above; the oomycete is soybean phytophthora sojae. The oomycete is preferably soybean phytophthora sojae P6497 strain.
[0031] The above method for reducing the ability of oomycetes to infect hosts is to reduce the ability of oomycetes to infect hosts by controlling hyphae growth; the host is soybean.
[0032] The above method for controlling the mycelial growth of soybean phytophthora is a method for controlling the mycelial growth of soybean phytophthora by knocking out any one of the above DNA sequences. The soybean phytophthora includes the soybean phytophthora P6497 strain.
[0033] In one embodiment of the present invention, the gene knockout method adopts a CRISPR / Cas9-based gene knockout method.
[0034] Specifically, the gene knockout method based on CRISPR / Cas9 is to transfect the Donor vector of the target gene and the sgRNA and Cas9 co-expression plasmid into soybean phytophthora to screen for recombinant bacteria in which the target knockout protein is inactivated.
[0035] The Donor vector is a recombinant vector containing a sequence of 800-1500 bp upstream of the target gene to be knocked out, a screening gene and a sequence of 800-1500 bp downstream of the target gene to be knocked out, which are sequentially connected.
[0036] Preferably, the Donor vector is a recombinant vector containing a sequence of 1000 bp upstream of the target gene to be knocked out, a screening gene, and a sequence of 1000 bp downstream of the target gene to be knocked out, which are sequentially connected. The screening gene is the NPTII gene, the sequence of 1000 bp upstream of the target gene has a DNA sequence of SEQ ID No.39, and the sequence of 1000 bp downstream of the target gene has a DNA sequence shown in SEQ ID No.40.
[0037] The sgRNA sequences expressed by the sgRNA and Cas9 co-expression plasmids were CCAGGCUUAGCGGAACCACUGAA and CCGGCAUGUCAGACACAGCCGCA, respectively.
[0038] Preferably, the sgRNA and Cas9 co-expression plasmid is a CRISPR-Cas9 system expression vector containing a DNA fragment encoding the sgRNA targeting the target gene to be knocked out, wherein the DNA encoding the sgRNA targeting the PsZFPK2 gene is the DNA shown in SEQ ID No.37 and SEQ ID No.38 in the sequence table.
[0039] Preferably, the sgRNA and Cas9 co-expression plasmid is a starting vector, which is PYF515 as a starting vector, and the DNA fragments shown in SEQ ID No.37 and SEQ ID No.38 are respectively inserted between the BsaI and NheI enzyme recognition sites of PYF515 to obtain a recombinant expression vector expressing sgRNA and Cas9.
[0040] The seventh invention provides a method for detecting the level of AGC protein kinase transcription containing FYVE domain in soybean phytophthora, which comprises selecting any 80-300 bp, especially 150-200 bp long target sequence in any one of the above DNA sequences for reverse transcription fluorescence quantitative PCR detection; preferably also comprising an internal reference sequence. The soybean phytophthora includes soybean phytophthora P6497 strain.
[0041] The eighth aspect of the present invention provides a primer sequence for amplifying the expression level of AGC protein kinase containing FYVE domain in soybean phytophthora, that is, a primer sequence for amplifying a target sequence, preferably the primer sequence is shown in SEQ ID No.5 and SEQ ID No.6; more preferably, the primer sequence of the internal reference sequence is shown in SEQ ID No.13-14. The soybean phytophthora includes soybean phytophthora P6497 strain.
[0042] A primer and / or primer pair for amplifying the full length of the DNA sequence encoding the above AGC protein kinase or any segment of the DNA sequence also falls within the protection scope of the present invention.
[0043] Experiments have shown that the AGC protein kinase provided by the present invention plays a role in the growth and development of soybean Phytophthora spp. The hyphae growth of the knockout transformants obtained by PEG-CaCl2-mediated protoplast transformation technology is severely slowed down (hyphae growth morphology of soybean Phytophthora spp. P6497 and the knockout mutant ΔPsZFPK2-1, and the missing phenotype of the complemented full-length transformant is restored ( Figure 4As shown). Therefore, the AGC protein kinase PsZFPK2 containing the FYVE domain in soybean phytophthora can regulate hyphae growth, and inhibiting the function of this protein can control the soybean phytophthora disease cycle and control the large-scale epidemic of the disease. The present invention provides a technical basis for further developing the development process and molecular detection technology of soybean phytophthora, as well as the prevention and control and research of plant diseases caused by soybean phytophthora. BRIEF DESCRIPTION OF THE DRAWINGS
[0044] Figure 1 This is an analysis diagram of the expression pattern of the PsZFPK2 gene of Phytophthora sojae in different developmental stages of Phytophthora sojae (the horizontal axes from left to right are: hyphae (MY), sporangium (SP), zoospore (ZO), resting spore (CY), resting spore germination (CG), and infection of soybean leaves for 1.5 hours, 3 hours, 6 hours, 12 hours, 24 hours, and 48 hours).
[0045] Figure 2 This is a schematic diagram of the knockout vector. The left side is a schematic diagram of the homology arm replacement vector, and the right side is a schematic diagram of the sgRNA vector.
[0046] Figure 3 The results of PCR identification of PsZFPK2 knockout mutants of soybean Phytophthora. From left to right are the wild-type soybean Phytophthora strain P6497, EV control strain, knockout mutants (ΔPsZFPK2-1, ΔPsZFPK2-2), complement mutant ΔPsZFPK2-C and complement control strain ΔPsZFPK2-EV.
[0047] Figure 4 These are the hyphal growth morphologies of the wild-type soybean Phytophthora strain P6497, EV control strain, knockout mutants (ΔPsZFPK2-1, ΔPsZFPK2-2), complemented mutant ΔPsZFPK2-C, and complemented control strain ΔPsZFPK2-EV.
[0048] Figure 5 This is a schematic diagram of the truncated fragments of the key region of PsZFPK2, which, from top to bottom, are a schematic diagram of the domain structure of the full-length fragment of the PsZFPK2 gene, a schematic diagram of the fragment of the truncated N-terminal region (i.e., ΔN), a schematic diagram of the fragment of the truncated FYVE domain (i.e., ΔF), and a schematic diagram of the fragment of the truncated STKc domain (i.e., ΔS).
[0049] Figure 6 The following are the mycelial growth morphology of mutants with truncated fragments of the key region of PsZFPK2. The following are the wild-type soybean Phytophthora strain P6497, PsZFPK2 knockout transformant, PsZFPK2 full-length complementing transformant and PsZFPK2 key region truncated complementing transformant.
[0050] Figure 7A graph showing the infection of soybean yellow seedlings with PsZFPK2 knockout mutant zoospores for 48 hours and the measurement of lesion length. Figure 7 A From left to right, the wild-type soybean Phytophthora strain P6497, EV control strain, knockout mutants (ΔPsZFPK2-1, ΔPsZFPK2-2), complement mutant ΔPsZFPK2-C and complement control strain ΔPsZFPK2-EV are shown. Figure 7 B is a graph showing the measurement of lesion length of the PsZFPK2 knockout mutant in soybean yellow seedlings. DETAILED DESCRIPTION
[0051] The following examples are provided to facilitate a better understanding of the present invention, but are not intended to limit the present invention. The experimental methods in the following examples are conventional methods unless otherwise specified. The materials, reagents, etc. used in the following examples are all commercially available unless otherwise specified.
[0052] The wild-type strain of Phytophthora sojae P6497 is a standard strain of Phytophthora sojae donated by Professor Brett M. Tyler of the United States. The above strains are only materials used in the examples of the present invention. In fact, when applying the screening markers of the present invention, any commercially available means can be used to obtain Phytophthora sojae strains.
[0053] The above strains have been identified by existing morphological and molecular biological methods.
[0054] Example 1: Cloning of the AGC protein kinase PsZFPK2 gene containing the FYVE domain from Phytophthora sojae
[0055] 1.1 Extraction of total RNA from Phytophthora sojae
[0056] After the soybean phytophthora strain P6497 was cultured in the dark at 25°C for 4 days on a 10% V8 solid medium, a 5 mm diameter cake was taken from the edge of the colony and inoculated into a 10% V8 liquid medium. After 2 days of dark culture at 25°C, the mycelia were collected, and about 30 mg of mycelia were taken and placed in a 2 mL enzyme-free sterile centrifuge tube, and two 5 mm diameter steel balls were added. After freezing with liquid nitrogen, the tube was ground into powder using a ball mill. The soybean phytophthora RNA was extracted using the SV Total RNA Extraction Kit (Z3100) of Promega Company. The specific method steps refer to the instructions for RNA extraction from plant tissues in the kit.
[0057] 1.2 Synthesis of first-strand cDNA from reverse transcription of Phytophthora sojae
[0058] The first-strand cDNA was synthesized by Takara RT reagent Kit with gDNAEraser (Perfect Real Time) Kit (RR047A). The specific steps are as follows:
[0059] (1) Removal of genomic DNA (10 μL reaction system): 2 μL of 5× gDNA Eraser Buffer; 1 μL of gDNA Eraser; 2 μL of total RNA; 5 μL of RNase-free ultrapure water.
[0060] (2) Reverse transcription reaction (10 μL reaction system): 10 μL of the reaction solution in step (1); 5× Buffer 4 μL; RT Enzyme Mix I 1 μL; RT Primer Mix 1 μL; RNase-free ultrapure water 4 μL.
[0061] Reaction conditions: 37°C for 15 min; 85°C for 5 s; stored at 4°C. The obtained cDNA was diluted 4 times for Real-time PCR reaction.
[0062] 1.3 PsZFPK2 gene cloning
[0063] Primers for cloning the AGC protein kinase gene containing the FYVE domain in Phytophthora sojae were designed, PsZFPK2-F: ATGAAGAAGTCTCCCGTGGCTG (SEQ ID No. 1); PsZFPK2-R: CTAGATGATCTGCGACTCGGGCTC (SEQ ID No. 2). The cDNA and genome of Phytophthora sojae obtained in step 1.2 were used as templates, and PCR amplification was performed using the above primers. The amplified products were recovered and connected to T1-simple Vector (Beijing Quanshijin Biotechnology Co., Ltd., Beijing) and transformed into Escherichia coli T1 competent cells. Positive clones were screened, and the plasmids of the positive clones were extracted for sequencing. The sequencing results showed that the cDNA of the PsZFPK2 gene had the nucleotide sequence shown in SEQ ID No. 3. The inventors showed through genome amplification and sequencing that its coding gene was consistent with the cDNA sequence. SEQ ID No. 3 consists of 2724 nucleotides and encodes a protein consisting of 907 amino acids (sequence shown in SEQ ID No. 4), and the protein was named PsZFPK2. The sequence of the FYVE domain is the amino acid residue sequence from 360 to 422 at the amino terminal of SEQ ID No.4.
[0064] SEQ ID No.3:
[0065]
[0066]
[0067]
[0068] SEQ ID No.4:
[0069]
[0070] Example 2: Analysis of the expression pattern of PsZFPK2 gene at different developmental stages of Phytophthora sojae
[0071] Kit used: TakaraTB Green TM Premix Ex Taq TM II (Tli RNaseH Plus) (Code: RR820A). Dilute the cDNA samples of hyphae stage to 0, 4, 4 2 , 4 3 , 4 4 , 4 5 , 4 6 The real-time fluorescence quantitative PCR standard curve was established with PsActin (primer sequences see SEQ ID No. 13, SEQ ID No. 14) as the internal reference gene and PsZFPK2 as the detection gene. The gene primer amplification efficiency should be above 90%, and the appropriate dilution sample concentration should be selected for the next step of the test.
[0072] Samples from different developmental and infection stages were diluted 4 times as templates, PsActin was used as the internal reference gene, and the detection primers PsZFPK2-qPCR F / PsZFPK2-qPCRR (sequences see SEQ ID No.5, SEQ ID No.6) were used for real-time fluorescence quantitative PCR detection. The qPCR reaction system was 20 μL: 10 μL TB Green Premix Ex Taq II, 1.6 μL template, 0.8 μL F / R primers, 6.8 μL ddH2O. The reaction procedure was a two-step method: 95°C 30s; 95°C 5s, 60°C 30s, 40 cycles. -ΔΔCt The relative expression level of PsZFPK2 gene at different developmental stages of Phytophthora sojae was calculated.
[0073] The results are as follows Figure 1 As described above, normalized to the mycelial stage (MY) of P6497 of soybean phytophthora, the expression level of PsZFPK2 was higher at 12h and 24h in the middle stage of soybean phytophthora infection, and the expression level decreased significantly at 48h in the late stage of infection.
[0074] Example 3: Obtaining knockout transformants of the PsZFPK2 gene of Phytophthora sojae
[0075] 3.1 Construction of knockout vector for PsZFPK2 gene of Phytophthora sojae
[0076] (1) Obtain candidate sgRNA
[0077] The sgRNA of PsZFPK2 was designed by EuPaGDT (http: / / grna.ctegd.uga.edu / ), and the full length of the genome was input into the website for search.
[0078] (2) Secondary structure screening
[0079] The secondary structure of the candidate sgRNA was analyzed using a website tool (http: / / rna.urmc.rochester.edu / RNAstructureWeb / Servers / Predict1 / Predict1.html), and the candidate sgRNAs with the number of hairpin complementary bridges less than or equal to 3 were selected.
[0080] (3) Off-target analysis
[0081] The sgRNA was analyzed for off-target by FungiDB ( www.fungidb.org ), and a total of 23 bases including the PAM region were input for comparison. In the case of a complete match between 9 and 23 (including NGG), the risk of off-target was considered to be high.
[0082] (4) Selecting an ideal sgRNA for synthesis (the DNA molecule sequences expressing sgRNA are shown in SEQ ID No. 37 and SEQ ID No. 38, and the sgRNA sequences are CCAGGCUUAGCGGAACCACUGAA and CCGGCAUGUCAGACACAGCCGCA, respectively. The 5' end nucleic acid sequence of SEQ ID No. 3 in the sequence list is targeted at positions 1318-1340 and positions 1229-1251, respectively.
[0083] (5) PYF515 (published vector, Fang Y, Cui L, Gu B, et al. 2017. Efficient genome editing in the oomycete Phytophthora sojae using CRISPR / Cas9. Current Protocols in Microbiology, 44: 21A.1.1-21A.1.26.) was used as the backbone vector and an sgRNA expression vector (structure as shown in the example) was constructed according to the published method (recorded in Fang Y, Cui L, Gu B, et al. 2017. Efficient genome editing in the oomycete Phytophthora sojae using CRISPR / Cas9. Current Protocols in Microbiology, 44: 21A.1.1-21A.1.26.). Figure 2sgRNA vector in the middle). Annealing treatment of sgRNA encoding DNA (30μL system): 3μL positive strand, 3μL antisense strand, 3μL 10×T4 DNA Ligase Buffer (NEB), 2μL T4Ligase and 19μLddH2O, 37℃, 30min; add 4μL 0.5M NaCl, 100℃, 2min; slowly cool at room temperature for about 3-4h; dilute 1μL, add 499μL ddH2O; select restriction sites BsaI and NneI to cut PYF515 plasmid to linearize the plasmid; connect plasmid: 3μL diluted annealed sgRNA fragment encoding DNA (sequence see SEQ ID No.37 and SEQ IDNo.38), 2μL 10×T4 DNA Ligase Buffer (NEB), 1μL T4 DNA Ligase, 50ng PYF515 linear plasmid, ddH2O to 20μL, 25℃, 30min. The ligation product was transferred into E. coli DH5α competent cells, ice bathed for 30min, heat shock at 42℃, 35s, ice bathed for 2min, added to non-resistant LB and shaken for 60min, the bacterial solution was spread on the LB plate with Amp resistance, and after overnight culture at 37℃, the universal primers M13F (sequence: TGTAAAACGACGGCCAGT) / RPL41-F (sequence: CAAGCCTCACTTTCTGCTGACTG) were used for amplification and sequencing to verify the clone. The recombinant vector containing the fragment shown in SEQ ID No.37 that was verified to be correct was named PYF515-sgRNA1, and the expression of the nucleic acid sequence at positions 1318-1340 at the 5' end of SEQ ID No.3 in the targeting sequence list was targeted; the recombinant vector containing the fragment shown in SEQ ID No.38 that was verified to be correct was named PYF515-sgRNA2, and the expression of the nucleic acid sequence at positions 1229-1251 at the 5' end of SEQ ID No.3 in the targeting sequence list was targeted.
[0084] (6) Using the genomic DNA of soybean Phytophthora sojae P6497 as a template, a primer pair (sequences of the primer pair for the 1000 bp fragment upstream of the gene are shown in SEQ ID No. 7 and SEQ ID No. 8, and the primer pair for the 1000 bp fragment downstream of the gene are shown in SEQ ID No. 11 and SEQ ID No. 12) was used to amplify the 1000 bp fragment upstream of the target gene (sequence is shown in SEQ ID No. 39) and the 1000 bp fragment downstream of the gene (sequence is shown in SEQ ID No. 40); using PYF515 as a template, a primer pair (sequence is shown in SEQ ID No. 9 and SEQ ID No. 10) was used to amplify the NPTII fragment (sequence is shown in Fang Y, Cui L, Gu B, et al. 2017. Efficient genome editing in the oomycete Phytophthora sojae using CRISPR / Cas9. Current Protocols in Microbiology, 44: 21A.1.1-21A.1.26.). pBluescript II SK + As the backbone vector, select restriction sites EcoRI and BamHI (enzymes purchased from NEB) to digest pBluescript II SK + Plasmid, using In-fusion kit (Takara Code No.639650) to construct homology arm replacement vector (structure as Figure 2 Donor vector). HD Cloning Kit fused the three amplified fragments into the cloning vector pBluescript II SK + (EcoRI and BamHI digestion), 50℃, 15min later, the ligation product was transferred into Escherichia coli DH5α competent cells, ice bath for 30min, heat shock at 42℃, 35s, ice bath for 2min, add resistance-free LB and shake culture for 60min, spread the bacterial solution on LB plate with Amp resistance, culture at 37℃ overnight, use universal primers M13F (sequence: TGTAAAACGACGGCCAGT) / M13R (sequence: CAGGAAACAGCTATGACC) to amplify and sequence the clone, and the verified recombinant expression vector containing the sequentially connected 1000bp sequence of PsZFPK2 upstream, NPTII gene sequence and 1000bp sequence of PsZFPK2 downstream was named pBS-NPTII-PsZFPK2.
[0085] 3.2 Obtaining knockout transformants of the PsZFPK2 gene of Phytophthora sojae
[0086] The PsZFPK2 gene knockout transformants were obtained by CaCl2-PEG-mediated protoplast transformation method (described in Fang and Tyler, 2016. Efficient disruption and replacement of an effector gene in the oomycete Phytophthora sojae using CRISPR / Cas9). Specifically, the sgRNA expression vectors constructed in 3.1 (PYF515-sgRNA1 and PYF515-sgRNA2 were transferred together in three groups, the first group: PYF515-sgRNA1; the second group: PYF515-sgRNA2; the third group: PYF515-sgRNA1 and PYF515-sgRNA2) were respectively and simultaneously transformed with the homology arm replacement vector pBS-NPTII-PsZFPK2 into protoplasts, and then transferred into soybean Phytophthora P6497. The grown transformants were cultured and screened on G418-resistant V8 plates at 25°C, and mycelium blocks were taken from the edge of the colony and inoculated on V8 plates covered with cellophane. After culturing at 25°C in the dark for 6 days, the mycelium was scraped and the DNA of the transformant samples was extracted.
[0087] Three pairs of primers were used to verify the knockout transformants. The primer pairs PsZFPK2-QCYZ-F1 / R1 (see sequence 15 and sequence 16 in the sequence list) and PsZFPK2-QCYZ-F2 / R2 (see sequence 17 and sequence 18 in the sequence list) were used to verify whether the gene had been replaced, and PsZFPK2-QCYZ-F3 / R3 (see sequence 19 and sequence 20 in the sequence list) was used for internal verification of the gene. If PsZFPK2-QCYZ-F1 / R1 and PsZFPK2-QCYZ-F2 / R2 have bands when performing PCR amplification on the suspected transformant, and PsZFPK2-QCYZ-F3 / R3 has no bands when performing PCR amplification on the suspected transformant, the suspected transformant can be identified as a positive homozygous transformant; if PsZFPK2-QCYZ-F1 / R1 and PsZFPK2-QCYZ-F2 / R2 have no bands when performing PCR amplification, and PsZFPK2-QCYZ-F3 / R3 has bands when performing PCR amplification, the transformant can be identified as the control strain EV; if all three pairs of primers have bands, the suspected transformant can be identified as a positive heterozygous transformant. Figure 3 As shown, a total of 2 homozygous PsZFPK2 knockout transformants were obtained, namely: ΔPsZFPK2-1 and ΔPsZFPK2-2, and 1 control strain EV.
[0088] Example 4: Obtaining in situ complementation transformants of the PsZFPK2 gene of Phytophthora sojae
[0089] Using the genomic DNA of soybean phytophthora P6497 as a template, primer pairs (sequences of the primer pairs of the 1000bp fragment upstream of the gene are shown in SEQ ID No.21 and SEQ ID No.22, and the primer pairs of the 1000bp fragment downstream of the gene are shown in SEQ ID No.25 and SEQ ID No.26) were used to amplify the 1000bp fragment upstream (sequence shown in SEQ ID No.39) and the 1000bp fragment downstream (sequence shown in SEQ ID No.40) of the target gene respectively; using the genomic DNA of soybean phytophthora P6497 as a template, primer pairs (sequence shown in SEQ ID No.23 and SEQ ID No.24) were used to amplify the full-length fragment of PsZFPK2. pBluescript II SK + As the backbone vector, select restriction sites EcoRI and BamHI (enzymes purchased from NEB) to digest pBluescript II SK + Plasmid, homology arm replacement vector was constructed by In-fusion kit (Takara Code No.639650). HD Cloning Kit fused the three amplified fragments into the cloning vector pBluescript II SK + (EcoRI and BamHI digestion), 50℃, 15min later, the ligation product was transferred into Escherichia coli DH5α competent cells, ice bath for 30min, heat shock at 42℃, 35s, ice bath for 2min, add resistance-free LB and shake culture for 60min, spread the bacterial solution on LB plate with Amp resistance, culture at 37℃ overnight, use universal primers M13F (sequence: TGTAAAACGACGGCCAGT) / M13R (sequence: CAGGAAACAGCTATGACC) for amplification and sequencing to verify the clone, and the verified recombinant expression vector containing the sequentially connected PsZFPK2 upstream 1000bp sequence, PsZFPK2 full-length sequence and PsZFPK2 downstream 1000bp sequence was named PBS-PsZFPK2 full-length complementation, and the PsZFPK2 full-length in situ complementation vector was obtained by sequencing.
[0090] Using cDNA as a template, primers (SEQ ID No. 23 and SEQ ID No. 24) were used to amplify the full-length fragment of PsZFPK2, such as Figure 5 PsZFPK2, amplified product 2724 nucleotides), amplified the key domain truncated fragment (sequence SEQ ID No.27 and SEQ ID No.28 amplified the fragment of the truncated N segment region of the key domain truncation complement vector, that is, Figure 5 ΔPsZFPK2-C ΔN, the amplified product has a total of 1779 nucleotides; sequences SEQ ID No.29, SEQ ID No.30, SEQ ID No.31 and SEQ ID No.32 are used to amplify the fragment of the truncated FYVE domain for constructing the key domain truncation complementation vector, namely Figure 5 ΔPsZFPK2-C ΔFYVE , the amplified product has a total of 2535 nucleotides; sequences SEQ ID No.33, SEQ ID No.34, SEQ ID No.35, and SEQ ID No.36 are used to amplify the fragment of the STKc domain for constructing the key domain truncation complementation vector, that is, Figure 5 ΔPsZFPK2-C ΔSTKc The amplified product totaled 1959 nucleotides. HD Cloning Kit (Takara Code No. 639650) was used to construct the PsZFPK2 key domain truncation complement vector, and the amplified fragments corresponding to each truncation were fused and connected to the vector pBluescript II SK + (EcoRI and BamHI digestion), after 50℃ for 15min, the ligation product was transferred into Escherichia coli DH5α competent cells, ice bath for 30min, heat shock at 42℃ for 35s, ice bath for 2min, add resistance-free LB and shake culture for 60min, spread the bacterial solution on LB plate with Amp resistance, and culture at 37℃ overnight. Primers pTOR-F (sequence: CCAAGTCCCAACCGACTCTT) / pTOR-R (sequence: GTTCTACAAACGGCCTTCTT) were used for amplification and sequencing verification of clones, and the verified recombinant expression vectors were named PYF3-PsZFPK2-ΔN, PYF3-PsZFPK2-ΔF, and PYF3-PsZFPK2-ΔS, respectively.
[0091] The PsZFPK2 knockout transformant ΔPsZFPK2-1 obtained in 3.2 was used as the experimental material, PBS-PsZFPK2, PBS-PsZFPK2-ΔN, PBS-PsZFPK2-ΔFYVE, and PBS-PsZFPK2-ΔSTKc were used as complementation vectors, and CaCl2-PEG-mediated protoplast transformation was used, and primer pairs (sequences are shown in SEQ ID No. 15 and 20) were used to verify the acquisition of complementation transformants of the full-length and truncated PsZFPK2. The correctly verified full-length complementation transformant of PsZFPK2 was named ΔPsZFPK2-C; the correctly verified complementation transformant of the fragment of the truncated N-terminal region was named ΔPsZFPK2-C ΔN The complement transformant with the correct truncated FYVE domain was named ΔPsZFPK2-C ΔFYVEThe complement transformant with the correct truncated STKc domain was named ΔPsZFPK2-C ΔSTKc The transformant that underwent complementation experiment but failed to complement was used as a control and named ΔPsZFPK2-EV.
[0092] Example 5. Analysis of biological characteristics of knockout transformants of PsZFPK2 gene of Phytophthora sojae
[0093] (1) Mycelium growth rate detection
[0094] The wild type P6497, knockout transformant control strain EV, knockout transformant ΔPsZFPK2-1, ΔPsZFPK2-2, complement transformant ΔPsZFPK2-C and complement control transformant ΔPsZFPK2-EV were cultured in the dark at 25°C for 6 days, and then the bacterial cakes were punched along the edge of the colony with a 5mm diameter puncher and inoculated on V8 plates. The plates were cultured in the dark at 25°C for 6 days, and the colony diameters were measured by the cross method. The experiment was repeated three times. P. sojae P6497 was used as the control.
[0095] like Figure 4 As shown, compared with the wild-type soybean Phytophthora strain P6497 and the control strain EV, the mycelial growth rate of the knockout mutants ΔPsZFPK2-1 and ΔPsZFPK2-2 was significantly reduced, and the mycelial growth rate of the complement transformant ΔPsZFPK2-C was restored.
[0096] (2) Pathogenicity of the transformants in vitro
[0097] Pathogenicity of zoospores in vitro yellow flower seedlings: After culturing in the dark at 25°C for 6 days, wild-type P6497, knockout transformant control strain EV, knockout transformant ΔPsZFPK2-1, ΔPsZFPK2-2, complement transformant ΔPsZFPK2-C and complement control transformant ΔPsZFPK2-EV, the mycelium was resuspended and rinsed 7 times with 20 mL of sterile water, each time with an interval of 30 minutes, and placed at room temperature for 4 hours to wait for zoospores to be produced, which was conducive to the hemocytometer to adjust 1 μl of spore suspension to contain 20 zoospores per treatment, and two layers of absorbent paper were spread in a fresh-keeping box, and an appropriate amount of deionized water was poured in and ten robust soybean yellow flower seedlings of the same age were placed. The zoospores were inoculated in soybean yellow flower seedlings, and 10 μl was inoculated in each piece and yellow flower seedlings, and at least 10 yellow flower seedlings were inoculated in each group. The inoculated soybean yellow flower seedlings were placed at 25°C (RH=60%-80%) and cultured in the dark for 2 days. The length of the lesions was measured and recorded and photographed. The experiment was repeated three times. Soybean Phytophthora P6497 was used as the control.
[0098] like Figure 7As shown, compared with the wild-type soybean Phytophthora strain P6497 and the control strain EV, the lesion length of the knockout mutants ΔPsZFPK2-1 and ΔPsZFPK2-2 was significantly reduced, and the lesion length of the complement transformant ΔPsZFPK2-C was restored.
[0099] Example 6: Analysis of biological characteristics of truncated and complemented transformants of PsZFPK2 gene of Phytophthora sojae
[0100] (1) Determination of hyphae growth rate of truncated complement transformants
[0101] The test strains were soybean Phytophthora strain P6497, PsZFPK2 gene knockout transformant ΔPsZFPK2-1, PsZFPK2 full-length complement transformant ΔPsZFPK2-C, and truncated N-terminal region complement transformant ΔPsZFPK2-C. ΔN , complement transformant ΔPsZFPK2-C with truncated FYVE domain ΔFYVE , complement transformant ΔPsZFPK2-C with truncated STKc domain ΔSTKc The colonies were inoculated on V8 plates. After 6 days of incubation at 25°C in the dark, the colony diameters were measured using the cross method. The experiment was repeated three times. Soybean Phytophthora P6497 was used as the control.
[0102] like Figure 6 As shown, the phenotype of the full-length complemented strain ΔPsZFPK2-C can be completely restored to the wild-type strain P. sojae P6497; the complemented transformant ΔPsZFPK2-C with the truncated N-terminal region ΔN , complement transformant ΔPsZFPK2-C with truncated FYVE domain ΔFYVE and the complement transformant ΔPsZFPK2-C with truncated STKc domain ΔSTKc None of them could restore the hyphal growth defect, indicating that each domain is necessary for PsZFPK2 to perform its biological function.
Claims
1. Use of the gene encoding the AGC protein kinase containing the FYVE domain as shown in SEQ ID No.3 or its encoded protein in controlling the growth rate of oomycete hyphae and / or reducing the pathogenicity of oomycetes, wherein the oomycete is soybean phytophthora ( Phytophthora sojae ).
2. The use according to claim 1, characterized in that: The oomycete is Phytophthora sojae ( Phytophthora sojae )P6497.
3. A method for reducing the pathogenicity of an oomycete and / or reducing the ability of an oomycete to infect a host, comprising inhibiting the expression of or inactivating a gene encoding an AGC protein kinase containing a FYVE domain in the oomycete to obtain an oomycete with reduced pathogenicity and / or reduced ability to infect a host; the sequence of the gene encoding the AGC protein kinase containing a FYVE domain is shown in SEQ ID No. 3; the oomycete is Phytophthora sojae ( Phytophthora sojae ).
4. The method according to claim 3, characterized in that The method for inhibiting the expression of the coding gene of the AGC protein kinase containing the FYVE domain in the oomycete or inactivating it is to knock out the coding gene.
5. The method according to claim 4, characterized in that The host is soybean; the oomycete is soybean phytophthora ( Phytophthora sojae )P6497.
6. A method for inhibiting or blocking the growth of oomycete hyphae, comprising inhibiting or blocking the growth of the oomycete hyphae by inhibiting the expression of a gene encoding an AGC protein kinase containing a FYVE domain in the oomycete or inactivating the gene; the oomycete is Phytophthora sojae ( Phytophthora sojae ).
7. The method according to claim 6, characterized in that The method for inhibiting the expression of the coding gene of the AGC protein kinase containing the FYVE domain in the oomycete or inactivating it is to knock out the coding gene.
